PDF herunterladen
J Neurol Surg A Cent Eur Neurosurg 2023; 84(04): 377-385
DOI: 10.1055/s-0041-1741530
Review Article

Therapeutic Strategies in Traumatic Intracranial Hemorrhage and Outcomes

Amanjung Singh
1   Division of Trauma, Jersey Shore University Medical Center, Neptune, New Jersey, United States
,
Radhika Trivedi 
1   Division of Trauma, Jersey Shore University Medical Center, Neptune, New Jersey, United States
,
Nasim Ahmed
2   Division of Trauma and Surgical Critical Care, Jersey Shore University Medical Center, Neptune, New Jersey, United States
3   Hackensack Meridian School of Medicine, Nutley, New Jersey, United States
› Institutsangaben Funding None.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background Traumatic intracranial hemorrhage (TICH) and its progression have historically resulted in poor prognosis and functional disability. Such outcomes can impact the daily lives and financial condition of patients' families as well as add burden to the health care system. This review examines the diverse therapeutic intervention that were observed in randomized clinical trials (RCT) on various outcomes. Many demographic and clinical risk factors have been identified for poor prognosis after a TICH. Among the many therapeutic strategies studied, few found to have some beneficial effect in minimizing the progression of hemorrhage and reducing the overall mortality.

Methods A literature review was conducted of all relevant sources using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to include articles that were RCTs for patients aged 18 years and above to include a total of 19 articles.

Results Across studies, many therapies have been assessed; however, only few findings including infusion of tranexamic acid (TXA), use of β-blocker, and early operative evacuation of TICH yielded favorable results. Use of steroid and blood transfusion to target higher hemoglobin levels showed evidence of adversely impacting the outcome.

Conclusion Of the many therapeutic strategies available for TICH, very few therapies have proven to be beneficial

Keywords

traumatic intracranial hemorrhage - expansion - interventions - outcomes

Availability of Data and Material

Data used in this study were collected from prior studies and are available for use.


Ethics Approval

This study was exempt from requiring ethics approval because this was a review of existing studies and did not involve human or animal participants.


Authors' Contributions

A.S. and R.T. collected and analyzed the resources, and wrote the manuscript. N.A. is the Principal Investigator and corresponding author, and conceived and designed the review, collected and analyzed resources, and wrote the manuscript.




Publikationsverlauf

Eingereicht: 22. Juni 2021

Angenommen: 15. November 2021

Artikel online veröffentlicht:
14. Februar 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Centers for Disease Control and Prevention. Traumatic brain injury/concussion. 2020 . Accessed February 12, 2021 at https://www.cdc.gov/traumaticbraininjury/index.html
    PubMedGoogle Scholar
  • 2 Centers for Disease Control and Prevention. Surveillance Report of Traumatic Brain Injury-related Emergency Department Visits, Hospitalizations, and Deaths—United States, 2014. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2019
    Google Scholar
  • 3 Kachmann M, Dale H. Traumatic Brain injury. Cincinnati, OH: Mayfield Brain & Spine. 2018 . Available at: http://mayfieldclinic.com/pe-tbi.htm
    PubMedGoogle Scholar
  • 4 Agarwal N, Thakkar R, Than K. Traumatic Brain Injury. 2020 . Available at: http://www.aans.org/Patients/Neurological-conditions-and-reatments/Traumatic-Brain-Injury
    PubMedGoogle Scholar
  • 5 Perel P, Roberts I, Bouamra O. et al. Intracranial bleeding in patients with traumatic brain injury: a prognostic study. BMC Emerg Med 2009; 9: 15
    CrossrefPubMedGoogle Scholar
  • 6 Narayan RK, Maas AI, Servadei F, Skolnick BE, Tillinger MN, Marshall LF. Traumatic Intracerebral Hemorrhage Study Group. Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma 2008; 25 (06) 629-639
    CrossrefPubMedGoogle Scholar
  • 7 Oertel M, Kelly DF, McArthur D. et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg 2002; 96 (01) 109-116
    CrossrefPubMedGoogle Scholar
  • 8 Jokar A, Ahmadi K, Salehi T, Sharif-Alhoseini M, Rahimi-Movaghar V. The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial. Chin J Traumatol 2017; 20 (01) 49-51
    CrossrefPubMedGoogle Scholar
  • 9 Roberts I, Shakur-Still H. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019; 394 (10210): 1713-1723
    CrossrefPubMedGoogle Scholar
  • 10 Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg 2018; 109: e748-e753
    CrossrefPubMedGoogle Scholar
  • 11 Ebrahimi P, Mozafari J, Ilkhchi RB, Hanafi MG, Mousavinejad M. Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials 2019; 14 (04) 286-291
    CrossrefPubMedGoogle Scholar
  • 12 Joseph B, Pandit V, Sadoun M. et al. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg 2013; 75 (06) 990-994
    CrossrefPubMedGoogle Scholar
  • 13 Zhang LM, Li R, Sun WB. et al. Clinical, prospective randomized, controlled study of low-dose, early fresh frozen plasma transfusion therapy after severe traumatic brain injury. World Neurosurg 2019; 132: 21-27
    CrossrefPubMedGoogle Scholar
  • 14 Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg 2007; 109 (02) 166-171
    CrossrefPubMedGoogle Scholar
  • 15 Narayan RK, Maas AI, Marshall LF, Servadei F, Skolnick BE, Tillinger MN. rFVIIa Traumatic ICH Study Group. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery 2008; 62 (04) 776-786 , discussion 786–788
    CrossrefPubMedGoogle Scholar
  • 16 Allard CB, Scarpelini S, Rhind SG. et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma 2009; 67 (05) 959-967
    PubMedGoogle Scholar
  • 17 Phelan HA, Wolf SE, Norwood SH. et al. A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: the Delayed Versus Early Enoxaparin Prophylaxis I (DEEP I) study. J Trauma Acute Care Surg 2012; 73 (06) 1434-1441
    CrossrefPubMedGoogle Scholar
  • 18 Grenander A, Bredbacka S, Rydvall A. et al. Antithrombin treatment in patients with traumatic brain injury: a pilot study. J Neurosurg Anesthesiol 2001; 13 (01) 49-56
    CrossrefPubMedGoogle Scholar
  • 19 Mendelow AD, Gregson BA, Rowan EN. et al; STITCH(Trauma) Investigators. Early Surgery versus Initial Conservative Treatment in Patients with Traumatic Intracerebral Hemorrhage (STITCH[Trauma]): the first randomized trial. J Neurotrauma 2015; 32 (17) 1312-1323
    CrossrefPubMedGoogle Scholar
  • 20 Prud'homme M, Mathieu F, Marcotte N, Cottin S. A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma. Can J Neurol Sci 2016; 43 (02) 284-290
    CrossrefPubMedGoogle Scholar
  • 21 Wang H, Cao H, Zhang X, Ge L, Bie L. The effect of hypertonic saline and mannitol on coagulation in moderate traumatic brain injury patients. Am J Emerg Med 2017; 35 (10) 1404-1407
    CrossrefPubMedGoogle Scholar
  • 22 Resnick DK, Marion DW, Darby JM. The effect of hypothermia on the incidence of delayed traumatic intracerebral hemorrhage. Neurosurgery 1994; 34 (02) 252-255 , discussion 255–256
    CrossrefPubMedGoogle Scholar
  • 23 Khalili H, Ahl R, Paydar S. et al. Beta-blocker therapy in severe traumatic brain injury: a prospective randomized controlled trial. World J Surg 2020; 44 (06) 1844-1853
    CrossrefPubMedGoogle Scholar
  • 24 Jiang R, Zhao S, Wang R. et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial. JAMA Neurol 2018; 75 (11) 1338-1346
    CrossrefPubMedGoogle Scholar
  • 25 Bai XF, Gao YK. Recombinant human erythropoietin for treating severe traumatic brain injury. Medicine (Baltimore) 2018; 97 (01) e9532
    CrossrefPubMedGoogle Scholar
  • 26 Eisenberg HM, Shenton ME, Pasternak O. et al. Magnetic resonance imaging pilot study of intravenous glyburide in traumatic brain injury. J Neurotrauma 2020; 37 (01) 185-193
    CrossrefPubMedGoogle Scholar
  • 27 Khalili H, Derakhshan N, Niakan A. et al. Effects of oral glibenclamide on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injuries: a randomized double-blind placebo-controlled clinical trial. World Neurosurg 2017; 101: 130-136
    CrossrefPubMedGoogle Scholar
  • 28 Vedantam A, Yamal JM, Rubin ML, Robertson CS, Gopinath SP. Progressive hemorrhagic injury after severe traumatic brain injury: effect of hemoglobin transfusion thresholds. J Neurosurg 2016; 125 (05) 1229-1234
    CrossrefPubMedGoogle Scholar
  • 29 Shakur H, Roberts I, Bautista R. et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376 (9734): 23-32
    CrossrefPubMedGoogle Scholar
  • 30 May AK, Young JS, Butler K, Bassam D, Brady W. Coagulopathy in severe closed head injury: is empiric therapy warranted?. Am Surg 1997; 63 (03) 233-236 , discussion 236–237
    PubMedGoogle Scholar